Advisor Group Holdings, Inc. Aurinia Pharmaceuticals Inc. Transaction History

Advisor Group Holdings, Inc.

  • $42.1 Billion
  • Q1 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 24,092 shares of AUPH stock, worth $194,904. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,092
Previous 25,796 6.61%
Holding current value
$194,904
Previous $231,000 16.45%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$7.55 - $8.77 $12,865 - $14,944
-1,704 Reduced 6.61%
24,092 $193,000
Q4 2024

Jun 06, 2025
BUY
$6.75 - $10.44 $141,338 - $218,603
20,939 Added 86.91%
45,031 $404,000
Q4 2024

Feb 07, 2025
BUY
$6.75 - $10.44 $4,596 - $7,109
681 Added 2.71%
25,796 $231,000
Q3 2024

Nov 13, 2024
BUY
$5.32 - $7.33 $75,911 - $104,591
14,269 Added 131.56%
25,115 $184,000
Q2 2024

Aug 13, 2024
SELL
$4.81 - $5.78 $1,981 - $2,381
-412 Reduced 3.66%
10,846 $61,000
Q1 2024

May 10, 2024
SELL
$4.93 - $9.31 $26,365 - $49,789
-5,348 Reduced 32.21%
11,258 $56,000
Q4 2023

Feb 12, 2024
BUY
$7.13 - $9.49 $684 - $911
96 Added 0.58%
16,606 $149,000
Q3 2023

Nov 13, 2023
BUY
$7.77 - $12.27 $21,857 - $34,515
2,813 Added 20.54%
16,510 $128,000
Q2 2023

Aug 10, 2023
BUY
$8.96 - $11.69 $53,437 - $69,719
5,964 Added 77.12%
13,697 $132,000
Q1 2023

May 12, 2023
SELL
$5.94 - $11.27 $22,233 - $42,183
-3,743 Reduced 32.62%
7,733 $84,000
Q4 2022

Feb 10, 2023
SELL
$4.11 - $8.14 $4,738 - $9,385
-1,153 Reduced 9.13%
11,476 $49,000
Q3 2022

Nov 14, 2022
SELL
$6.66 - $12.39 $27,905 - $51,914
-4,190 Reduced 24.91%
12,629 $95,000
Q2 2022

Aug 10, 2022
SELL
$8.95 - $12.8 $14,982 - $21,427
-1,674 Reduced 9.05%
16,819 $168,000
Q1 2022

May 04, 2022
BUY
$10.05 - $22.48 $6,060 - $13,555
603 Added 3.37%
18,493 $228,000
Q3 2021

Nov 05, 2021
SELL
$10.93 - $23.55 $180,006 - $387,844
-16,469 Reduced 47.93%
17,890 $395,000
Q2 2021

Aug 02, 2021
BUY
$10.0 - $14.52 $149,460 - $217,015
14,946 Added 76.99%
34,359 $444,000
Q1 2021

May 13, 2021
SELL
$12.3 - $18.73 $319,529 - $486,567
-25,978 Reduced 57.23%
19,413 $253,000
Q4 2020

Feb 10, 2021
BUY
$12.94 - $16.05 $337,229 - $418,279
26,061 Added 134.82%
45,391 $628,000
Q3 2020

Nov 12, 2020
BUY
$13.19 - $16.66 $30,337 - $38,318
2,300 Added 13.51%
19,330 $285,000
Q2 2020

Aug 14, 2020
BUY
$14.12 - $18.33 $138,799 - $180,183
9,830 Added 136.53%
17,030 $277,000
Q1 2020

May 18, 2020
BUY
$11.34 - $21.46 $81,648 - $154,512
7,200 New
7,200 $104,000

Others Institutions Holding AUPH

# of Institutions
239
Shares Held
64.9M
Call Options Held
1.1M
Put Options Held
772K
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.15B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email